(Q63966154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Diabetes and prostate cancer risk in the REDUCE trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

C Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

L Gerber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R S Rittmaster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

G L Andriole

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S J Freedland

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

326-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21709690%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2011.28

6 February 2020

exact match

0 references

cites work

Epidemiology of cancer of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Diabetes mellitus and risk of prostate cancer: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

A meta-analysis of diabetes mellitus and the risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Diabetes mellitus and risk of prostate cancer (United States).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Glycemic status and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Serum prostate-specific antigen levels in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Obesity-PSA relationship: a new formula

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Effect of dutasteride on the risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Glycemic control and prostate cancer progression: Results from the SEARCH database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28

Metformin and reduced risk of cancer in diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.28